Vaxcyte

$26.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.04 (-4.04%) Today
+$1.29 (+5.22%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Vaxcyte and other stocks, options, and ETFs commission-free!

About PCVX

Vaxcyte, Inc. engages in development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering, Ashish Khanna and Jeff Fairman on November 27, 2013 and is headquartered in San Francisco, CA. The listed name for PCVX is Vaxcyte, Inc. Common Stock.

CEO
Grant E. Pickering
Employees
—
Headquarters
Foster City, California
Founded
2013
Market Cap
1.26B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
325.91K
High Today
$25.89
Low Today
$24.11
Open Price
$25.74
Volume
274.44K
52 Week High
$58.48
52 Week Low
$17.80

Collections

PCVX Earnings

-$1.72
-$1.15
-$0.57
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 30, After Hours

You May Also Like

QQQN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure